233 related articles for article (PubMed ID: 16645899)
21. Lansoprazole: a comprehensive review.
Zimmermann AE; Katona BG
Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
[TBL] [Abstract][Full Text] [Related]
22. Effects of Tegoprazan, a Novel Potassium-Competitive Acid Blocker, on Rat Models of Gastric Acid-Related Disease.
Kim DK; Lee KH; Kim SJ; Kim SJ; Lee SJ; Park CH; Kim BT; Song GS; Moon BS; Ryu SY
J Pharmacol Exp Ther; 2019 Jun; 369(3):318-327. PubMed ID: 30894456
[TBL] [Abstract][Full Text] [Related]
23. Medical treatment of peptic ulcer.
Habeebullah CM; Prabhakar B
Trop Gastroenterol; 1994; 15(2):65-75. PubMed ID: 7831720
[No Abstract] [Full Text] [Related]
24. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
25. NMR of drugs and ligands bound to membrane receptors.
Watts A
Curr Opin Biotechnol; 1999 Feb; 10(1):48-53. PubMed ID: 10047509
[TBL] [Abstract][Full Text] [Related]
26. Pantoprazole, Prout and the proton pump.
Playford RJ; Podas T; Modlin I
Hosp Med; 1999 Jul; 60(7):500-4. PubMed ID: 10605542
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori: factors affecting eradication and recurrence.
Vakil N
Am J Gastroenterol; 2005 Nov; 100(11):2393-4. PubMed ID: 16279890
[TBL] [Abstract][Full Text] [Related]
28. Taxifolin and gastro-adhesive microparticles containing taxifolin promotes gastric healing in vivo, inhibits Helicobacter pylori in vitro and proton pump reversibly in silico.
Stenger Moura FC; Cechinel-Filho V; Greco FA; Venzon L; Meurer MC; França TCDS; Longo B; Somensi LB; Mariano LNB; Cruz AB; Macchiarulo A; Schoubben A; Ricci M; Belle Bresolin TM; da Silva LM
Chem Biol Interact; 2021 Apr; 339():109445. PubMed ID: 33741339
[TBL] [Abstract][Full Text] [Related]
29. Gastro protective and H(+), K(+)-ATPase/H. pylori inhibitory properties of pectic polysaccharides from potato.
Badanavalu Chandrashekar K; Dharmesh SM
Int J Biol Macromol; 2016 Mar; 84():385-93. PubMed ID: 26704999
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
31. Drugs for GERD and peptic ulcer disease.
Med Lett Drugs Ther; 2018 Jan; 60(1538):9-16. PubMed ID: 29309399
[No Abstract] [Full Text] [Related]
32. Comparison table: Drugs for GERD and peptic ulcer disease.
Med Lett Drugs Ther; 2018 Jan; 60(1538):e16-e18. PubMed ID: 29309400
[No Abstract] [Full Text] [Related]
33. [Role of proton pump inhibitors in the eradication therapy for Helicobacter pylori (overviews)].
Sugano K
Nihon Rinsho; 2002 Feb; 60 Suppl 2():627-31. PubMed ID: 11979859
[No Abstract] [Full Text] [Related]
34. Synthesis of 4-(phenylamino)quinoline-3-carboxamides as a novel class of gastric H+/K+-ATPase inhibitors.
Uchida M; Otsubo K; Matsubara J; Ohtani T; Morita S; Yamasaki K
Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):693-8. PubMed ID: 7600619
[TBL] [Abstract][Full Text] [Related]
35. Proton-pump inhibitors for gastric acid-related disease.
Franko TG; Richter JE
Cleve Clin J Med; 1998 Jan; 65(1):27-34. PubMed ID: 9465453
[TBL] [Abstract][Full Text] [Related]
36. Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats.
Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS
Biol Pharm Bull; 1998 May; 21(5):449-55. PubMed ID: 9635498
[TBL] [Abstract][Full Text] [Related]
37. [Proton pump inhibitors: Tenatoprazole (TU-199)].
Nakamura T
Nihon Rinsho; 2002 Feb; 60 Suppl 2():650-4. PubMed ID: 11979864
[No Abstract] [Full Text] [Related]
38. Pharmacology of proton pump inhibitors.
Shin JM; Sachs G
Curr Gastroenterol Rep; 2008 Dec; 10(6):528-34. PubMed ID: 19006606
[TBL] [Abstract][Full Text] [Related]
39. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
Mazure PA
Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
[No Abstract] [Full Text] [Related]
40. A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication.
Hsu PI; Lai KH; Lin CK; Chen WC; Yu HC; Cheng JS; Tsay FW; Wu CJ; Lo CC; Tseng HH; Yamaoka Y; Chen JL; Lo GH
Am J Gastroenterol; 2005 Nov; 100(11):2387-92. PubMed ID: 16279889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
